DE60007078D1 - Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa - Google Patents

Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa

Info

Publication number
DE60007078D1
DE60007078D1 DE60007078T DE60007078T DE60007078D1 DE 60007078 D1 DE60007078 D1 DE 60007078D1 DE 60007078 T DE60007078 T DE 60007078T DE 60007078 T DE60007078 T DE 60007078T DE 60007078 D1 DE60007078 D1 DE 60007078D1
Authority
DE
Germany
Prior art keywords
convulsive
derivatives
bulimia nervosa
treating bulimia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60007078T
Other languages
English (en)
Other versions
DE60007078T2 (de
Inventor
P Hoopes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60007078D1 publication Critical patent/DE60007078D1/de
Application granted granted Critical
Publication of DE60007078T2 publication Critical patent/DE60007078T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60007078T 1999-02-01 2000-01-31 Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa Expired - Fee Related DE60007078T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11805799P 1999-02-01 1999-02-01
US118057P 1999-02-01
PCT/US2000/002334 WO2000044374A1 (en) 1999-02-01 2000-01-31 Use of anticonvulsant derivatives for treating bulimia nervosa

Publications (2)

Publication Number Publication Date
DE60007078D1 true DE60007078D1 (de) 2004-01-22
DE60007078T2 DE60007078T2 (de) 2004-12-16

Family

ID=22376270

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60007078T Expired - Fee Related DE60007078T2 (de) 1999-02-01 2000-01-31 Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa

Country Status (23)

Country Link
EP (1) EP1148874B1 (de)
JP (1) JP2002535363A (de)
KR (1) KR100664618B1 (de)
CN (1) CN1196482C (de)
AR (1) AR029331A1 (de)
AT (1) ATE255892T1 (de)
AU (1) AU764703B2 (de)
BR (1) BR0007897A (de)
CA (1) CA2360677C (de)
CZ (1) CZ295594B6 (de)
DE (1) DE60007078T2 (de)
DK (1) DK1148874T3 (de)
ES (1) ES2211507T3 (de)
HU (1) HUP0105420A3 (de)
IL (1) IL144407A0 (de)
MX (1) MXPA01007758A (de)
NO (1) NO20013725L (de)
NZ (1) NZ513114A (de)
PT (1) PT1148874E (de)
TR (1) TR200102205T2 (de)
TW (1) TW565446B (de)
WO (1) WO2000044374A1 (de)
ZA (1) ZA200107212B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
ES2238999T3 (es) * 1999-02-24 2005-09-16 University Of Cincinnati Uso de derivados de sulfamato para tratar trastornos en el control de los impulsos.
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.

Also Published As

Publication number Publication date
KR20010101665A (ko) 2001-11-14
DK1148874T3 (da) 2004-03-29
KR100664618B1 (ko) 2007-01-04
BR0007897A (pt) 2001-10-30
ES2211507T3 (es) 2004-07-16
PT1148874E (pt) 2004-04-30
ZA200107212B (en) 2002-12-02
TW565446B (en) 2003-12-11
TR200102205T2 (tr) 2002-01-21
EP1148874A1 (de) 2001-10-31
CN1196482C (zh) 2005-04-13
CA2360677C (en) 2005-07-05
ATE255892T1 (de) 2003-12-15
AU764703B2 (en) 2003-08-28
NO20013725D0 (no) 2001-07-30
WO2000044374A1 (en) 2000-08-03
MXPA01007758A (es) 2003-06-24
NZ513114A (en) 2003-10-31
DE60007078T2 (de) 2004-12-16
EP1148874B1 (de) 2003-12-10
HUP0105420A3 (en) 2003-03-28
JP2002535363A (ja) 2002-10-22
CZ295594B6 (cs) 2005-08-17
AU2746200A (en) 2000-08-18
IL144407A0 (en) 2002-05-23
CA2360677A1 (en) 2000-08-03
AR029331A1 (es) 2003-06-25
HUP0105420A2 (hu) 2002-05-29
NO20013725L (no) 2001-07-30
CN1338931A (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
ATE394103T1 (de) Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE257379T1 (de) Verwendung von aryl- (oder heteroaryl-) azoylcarbinolderivaten zur behandlung von durch überschuss von substanz p hervorgerufenen beschwerden
DE69827126D1 (de) Verwendung von hypothalamus-hemmfaktor zur behandlung von ischämischen herzstörungen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE50014041D1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60021903D1 (de) Verwendung von zusammensetzungen zur textilpflege
DE69528992D1 (de) Verwendung von aromatischen halogenverbindungen zur behandlung der zellproliferation in säugetieren
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69939723D1 (de) Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE60007078D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
DE59705697D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
ATE433323T1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE69701458D1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
DE69937365D1 (de) Verfahren zur verwendung von aralkylsiloxanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee